Clevidipine Butyrate

For research use only.

Catalog No.S2080

1 publication

Clevidipine Butyrate Chemical Structure

CAS No. 167221-71-8

Clevidipine Butyrate is a dihydropyridine calcium channel blocker, uses as an agent for the reduction of blood pressure.

Selleck's Clevidipine Butyrate has been cited by 1 publication

Purity & Quality Control

Choose Selective Calcium Channel Inhibitors

Biological Activity

Description Clevidipine Butyrate is a dihydropyridine calcium channel blocker, uses as an agent for the reduction of blood pressure.
Calcium channel [1]



Solubility (25°C)

In vitro DMSO 91 mg/mL (199.42 mM)
Ethanol 3 mg/mL (6.57 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 456.32


CAS No. 167221-71-8
Storage powder
in solvent
Synonyms N/A
Smiles CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04143503 Completed -- Critical Illness Fresenius Kabi|IQVIA Commercial GmbH & Co. OHG November 5 2019 --
NCT02011321 Unknown status Drug: clevidipine Subarachnoid Hemorrhage|Cerebral Aneurysm|Vasospasm Intracranial Henry Ford Health System March 2014 Phase 2
NCT01938547 Suspended Drug: clevidipine Pediatric Perioperative Blood Pressure Management Chiesi Farmaceutici S.p.A. March 2014 Phase 4
NCT01480531 Withdrawn Drug: Clevidipine Aorta Aneurysm|Dissection of Aorta Duke University|The Medicines Company December 2011 Not Applicable
NCT01910532 Withdrawn Drug: Clevidipine Hypertension Mario Ammirati|Ohio State University April 2010 Phase 4
NCT01033370 Terminated Drug: clevidipine. Aortic Aneurysm|Aortic Disease Asma Zainab M.D.|The Medicines Company|The Methodist Hospital Research Institute November 2009 Phase 4

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Calcium Channel Signaling Pathway Map

Related Calcium Channel Products

Tags: buy Clevidipine Butyrate | Clevidipine Butyrate supplier | purchase Clevidipine Butyrate | Clevidipine Butyrate cost | Clevidipine Butyrate manufacturer | order Clevidipine Butyrate | Clevidipine Butyrate distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID